FAQ

myocyte enhancer factor 2A

Known as: MEF2A Transcription Factor, Muscle Enhancer Factor-2A, MEF2A Protein 
Myocyte-specific enhancer factor 2A (507 aa, ~55 kDa) is encoded by the human MEF2A gene. This protein plays a role in the regulation of both… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2002-2017
02420022017

Related topics

Related topics

10 relations
DNA-Binding ProteinsGenes, RegulatorHomo sapiensMEF2A gene
(More)

Broader (1)

MEF2 Transcription Factors

Related mentions per year

Related mentions per year

1937-2018
19401960198020002020
myocyte enhancer factor 2A
Transcription, Genetic
dna binding
Homo sapiens
Organogenesis
Genes, Regulator

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Inhibition of myocyte-specific enhancer factor 2A improved diabetic cardiac fibrosis partially by regulating endothelial-to-mesenchymal transition
Cardiac fibrosis is an important pathological process of diabetic cardiomyopathy, the underlying mechanism remains elusive. This… (More)
Is this relevant?
2015
2015
Myocyte Enhancer Factor 2A Regulates Hydrogen Peroxide-Induced Senescence of Vascular Smooth Muscle Cells Via microRNA-143.
Myocyte enhancer factor 2A (MEF2A) is involved in vascular smooth muscle cell (VSMC) proliferation, migration, and senescence… (More)
Is this relevant?
2013
2013
Epigallocatechin-3-gallate regulates the expression of Kruppel-like factor 4 through myocyte enhancer factor 2A
Epigallocatechin-3-gallate (EGCG), a powerful antioxidant and free ion scavenger found in green tea, exhibits inhibitory effects… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2012
Highly Cited
2012
Nuclear accumulation of HDAC4 in ATM deficiency promotes neurodegeneration in ataxia-telangiectasia
Ataxia telangiectasia is a neurodegenerative disease caused by mutation of the Atm gene. Here we report that ataxia… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Is this relevant?
2007
2007
Nemo-like kinase-myocyte enhancer factor 2A signaling regulates anterior formation in Xenopus development.
The development of anterior neural structure in Xenopus laevis requires the inhibition of bone morphogenic protein 4 and Wnt… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2007
2007
Exercise and CaMK activation both increase the binding of MEF2A to the Glut4 promoter in skeletal muscle in vivo.
In vitro binding assays have indicated that the exercise-induced increase in muscle GLUT4 is preceded by increased binding of… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2004
2004
ERK5 is targeted to myocyte enhancer factor 2A (MEF2A) through a MAPK docking motif.
One critical component in determining the specificity, and efficiency of MAPK (mitogen-activated protein kinase) substrate… (More)
Is this relevant?
2003
2003
Phosphatidylinositol 3-kinase regulates bone morphogenetic protein-2 (BMP-2)-induced myocyte enhancer factor 2A-dependent transcription of BMP-2 gene in cardiomyocyte precursor cells.
The growth and differentiation factor bone morphogenetic protein-2 (BMP-2) regulates cardiac development during vertebrate… (More)
Is this relevant?
2003
2003
p300/cAMP-response-element-binding-protein ('CREB')-binding protein (CBP) modulates co-operation between myocyte enhancer factor 2A (MEF2A) and thyroid hormone receptor-retinoid X receptor.
Thyroid hormone receptors (TRs) and members of the myocyte enhancer factor 2 (MEF2) family are involved in the regulation of… (More)
Is this relevant?
2002
2002
RNA interference reveals a requirement for myocyte enhancer factor 2A in activity-dependent neuronal survival.
RNA interference (RNAi) provides a powerful method of gene silencing in eukaryotic cells, including proliferating mammalian cells… (More)
Is this relevant?